U.S. Orders Medicaid Coverage of Viagra
WASHINGTON — The federal government ordered states to cover Viagra under their Medicaid programs Thursday, infuriating many of the nation’s governors, who swiftly accused U.S. health officials of costing them millions of dollars and ignoring their worries about the male impotence drug.
The unexpected directive, sent in a letter from the Department of Health and Human Services, told states that federal law requires them to pay for the expensive, enormously popular drug through Medicaid, the insurance program for the poor and disabled. Any state Medicaid program that covers prescription medicines, the letter said, must also pay for Viagra.
But states countered that in issuing its order, the federal government was putting them in the untenable position of covering Viagra for men while virtually none of them cover birth control or infertility treatments for women. And they said federal officials had rushed to condone Viagra just as warnings are beginning to surface that the drug’s huge popularity may be causing deaths among some men. Some state officials said they also feared that if the government insurance program pays for Viagra, it could have the unintended effect of creating a black market for the pills.
“What we know about some of the real danger signs of Viagra really raise serious concerns,” said Elaine Ryan, government affairs director for the American Public Welfare Assn. “To move forward . . . at this point, without the consultation of the states that will have to [bear] this burden, is unacceptable.”
Based on the association’s survey of several states, Ryan predicted that Viagra will add $100 million to $200 million nationwide to states’ Medicaid expenses. At a time when states are working to extend health insurance to more children and elderly and disabled people, they “can’t sustain this kind of cost,” she said.
Medicaid, the public insurance program for 36 million poor and disabled Americans, is a shared responsibility of the federal government and states. Nearly 4 million men are in the program.
The federal government pays slightly more than half the bills and decides which basic kind of benefits should be covered. But states are free to decide whether to pay for many additional services, including prescription drugs. In practice, however, every state has chosen to provide coverage for prescriptions.
The Viagra dispute involves exactly which drugs states must cover. Until now, at least a dozen states have chosen to cover the pill, which has the potential not only to overcome impotence but also to improve healthy men’s sexual performance. Other states have decided not to cover Viagra, while others were awaiting instructions from the federal government.
The timing of Thursday’s letter from Nancy-Ann Min DeParle, head of the Health Care Financing Administration, angered several states because they contended that the Department of Health and Human Services had promised to meet with state officials before settling the matter.
“That never happened,” said Jennifer Baxendell, the National Governors’ Assn.’s director of health legislation, who said the group is beginning to try to persuade members of Congress to consider overturning the Viagra decision.
In her letter, DeParle said that under a 1990 law, states must “with a few limited exceptions” include in their prescription drug coverage any medication that has been approved by the Food and Drug Administration. She said Viagra has been approved for treating impotence and does not fall within any of the exceptions, which include diet pills, smoking cessation products and fertility treatments.
But states argue that the exception for fertility drugs should pertain to Viagra.
Chris Peacock, a Health Care Financing Administration spokesman, said the agency considers impotence a separate medical problem from infertility. But Baxendell of the governors association countered: “Some of the states argue they are inextricably linked.”
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.